drugset / Trial / NCT04219904
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
Phase 0
Active not recruiting
25 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This trial studies how well positron emission tomography/magnetic resonance imaging (PET/MRI) scan works in checking patients with stage IA1-IB3 cervical cancer that can be removed by surgery (resectable). PET/MRI scan may help doctors learn more about the spread of the disease.
Timeline
- Start
- 2018-09-07
- Primary completion
- 2027-09-30
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Gadobutrol | Diagnostic / imaging agent | — | Intravenous |